| Clinuvel Pharmaceuticals Limited (CUV) ORDINARY FULLY PAID |
Health Care |
$635 |
SCENESSE efficacy in vitiligo - new cases presented at RDTC
|
8 Jan 2026 9:44AM |
$12.260 |
$12.640 |
risen by
3.10%
|
|
| L1 Global Long Short Fund Limited (GLS) ORDINARY FULLY PAID |
Financials |
$952 |
Monthly Net Tangible Asset Backing
|
8 Jan 2026 9:43AM |
$1.730 |
$1.740 |
risen by
0.58%
|
|
| Ampol Limited (ALD) ORDINARY FULLY PAID |
Energy |
$7,273 |
Notification regarding unquoted securities - ALD
|
8 Jan 2026 9:41AM |
$30.480 |
$30.520 |
risen by
0.13%
|
|
| Aguia Resources Limited (AGR) ORDINARY FULLY PAID |
Materials |
$35 |
Application for quotation of securities - AGR
|
8 Jan 2026 9:36AM |
$0.022 |
$0.021 |
fallen by
4.55%
|
|
| Credit Clear Limited (CCR) ORDINARY FULLY PAID |
Information Technology |
$125 |
Cleansing notice
|
8 Jan 2026 9:35AM |
$0.270 |
$0.260 |
fallen by
3.70%
|
|
| Ampol Limited (ALD) ORDINARY FULLY PAID |
Energy |
$7,273 |
Notification regarding unquoted securities - ALD
|
8 Jan 2026 9:34AM |
$30.480 |
$30.520 |
risen by
0.13%
|
|
| Perpetual Diversified Income Active ETF (DIFF) |
Financials |
$216 |
Monthly Derivatives Disclosure - December 2025
|
8 Jan 2026 9:34AM |
$10.040 |
$10.050 |
risen by
0.10%
|
|
| Fatfish Group Limited (FFG) ORDINARY FULLY PAID |
Financials |
$11 |
Proposed issue of securities - FFG
|
8 Jan 2026 9:33AM |
$0.007 |
$0.007 |
fallen by
0%
|
|
| Fatfish Group Limited (FFG) ORDINARY FULLY PAID |
Financials |
$11 |
FFG completes refinancing and $0.15 million drawdown
|
8 Jan 2026 9:32AM |
$0.007 |
$0.007 |
fallen by
0%
|
|
| Credit Clear Limited (CCR) ORDINARY FULLY PAID |
Information Technology |
$125 |
Application for quotation of securities - CCR
|
8 Jan 2026 9:32AM |
$0.270 |
$0.260 |
fallen by
3.70%
|
|
| Barrow Hanley Global Share Fund (Managed Fund) (GLOB) |
Financials |
$453 |
Units on issue and fund flows - December 2025
|
8 Jan 2026 9:32AM |
$4.960 |
$4.980 |
risen by
0.40%
|
|
| Perpetual Ethical SRI Fund (Managed Fund) (GIVE) |
Financials |
$14 |
Units on issue and fund flows - December 2025
|
8 Jan 2026 9:32AM |
$3.000 |
$3.000 |
fallen by
0%
|
|
| Perpetual Diversified Income Active ETF (DIFF) |
Financials |
$216 |
Units on issue and fund flows - December 2025
|
8 Jan 2026 9:32AM |
$10.040 |
$10.050 |
risen by
0.10%
|
|
| White Energy Company Limited (WEC) ORDINARY FULLY PAID |
Energy |
$15 |
Exclusive agency agreement for sale of briquettor machines
|
8 Jan 2026 9:32AM |
$0.032 |
$0.035 |
risen by
9.38%
|
|
WEC - Price-sensitive ASX Announcement
Full Release
Key Points
- Exclusive agency agreement with K.R. Komarek Inc. for BCB briquettor machines.
- Agreement commences post worldwide licence expiration on 17 January 2026.
- BCB technology developed by a CSIRO-led consortium.
- BCB technology transforms coal into higher energy briquettes without binders.
- Potential applications in South Africa's energy sector.
- Joint venture with Proterra Investment Partners in South Africa.
- Agreement has an initial 10-year term with automatic renewals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Activex Ardea Real Outcome Bond Fund (Managed Fund) (XARO) |
Financials |
$163 |
Monthly Redemptions, Units on issue & OTC Exposure
|
8 Jan 2026 9:31AM |
$24.890 |
$24.890 |
fallen by
0%
|
|
| Syntara Limited (SNT) ORDINARY FULLY PAID |
Health Care |
$54 |
SNT-4728 Phase 2 iRBD Parkinsons UK Trial fully recruited
|
8 Jan 2026 9:30AM |
$0.033 |
$0.033 |
fallen by
0%
|
|
SNT - Price-sensitive ASX Announcement
Full Release
Key Points
- Final patient recruited into Syntara’s Phase 2 trial of SNT-4728 for iRBD.
- iRBD affects around 2% of individuals over 50 and may lead to neurodegenerative diseases.
- Study tests SNT-4728's ability to reduce neuroinflammation linked to Parkinson’s.
- Study supported by Parkinson’s UK through the Parkinson’s Virtual Biotech program.
- Advanced brain imaging used to assess neuroinflammation reduction.
- Exploratory endpoint to assess clinical symptom improvement of iRBD.
- Recruitment completion marks a critical step for Syntara.
- Study’s results could influence future neurodegenerative disorder treatments.
- Potential to advance Syntara's clinical pipeline and development opportunities.
- Top-line results expected in Q2 CY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Altair Minerals Limited (ALR) ORDINARY FULLY PAID |
Materials |
$149 |
North Peters High-Grade Intercepts of 89m @ 2.40 g/t Au
|
8 Jan 2026 9:30AM |
$0.024 |
$0.025 |
risen by
4.17%
|
|
ALR - Price-sensitive ASX Announcement
Full Release
Key Points
- 89m @ 2.40g/t Au from 45m at North Peters
- 24m @ 7.17g/t Au from 51m at North Peters
- 63m @ 2.25g/t Au from 55m at North Peters
- 11m @ 7.38g/t Au from surface at North Peters
- New Kmung Prospect identified with high-grade potential
- Integration of results for target-priority model across Greater Oko
- Data from historical drilling and grab samples enhance exploration strategy
- Potential for district-scale mineralization over 50km in Greater Oko
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Chariot Resources Ltd (CC9) ORDINARY FULLY PAID |
Materials |
$37 |
Jinjianqiao MOU for Financing and Offtake
|
8 Jan 2026 9:29AM |
$0.175 |
$0.180 |
risen by
2.86%
|
|
CC9 - Price-sensitive ASX Announcement
Full Release
Key Points
- Non-binding MOU with Fujian Jinjianqiao New Energy Technology Co., Ltd.
- Potential offtake of lithium ores and concentrates from Nigerian projects.
- Financing arrangements to support project development.
- Evaluation of a lithium processing facility in Nigeria.
- Jinjianqiao has existing operations in Nigeria and a robust supply chain.
- MOU includes possible credit lines and offtake prepayment financing.
- Chariot retains the right to negotiate with other parties.
- Exclusivity period of up to 90 days if a project is selected.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Singular Health Group Ltd (SHG) ORDINARY FULLY PAID |
Health Care |
$78 |
Notification of cessation of securities - SHG
|
8 Jan 2026 9:27AM |
$0.280 |
$0.250 |
fallen by
10.71%
|
|
| Endeavour Group Limited (EDV) ORDINARY FULLY PAID |
Consumer Staple |
$6,770 |
Notification of cessation of securities - EDV
|
8 Jan 2026 9:27AM |
$3.680 |
$3.770 |
risen by
2.45%
|
|
| BPH Global Ltd (BP8) ORDINARY FULLY PAID |
Health Care |
$3 |
R&D Program Focused on Gold and Silver Recovery from Seaweed
|
8 Jan 2026 9:27AM |
$0.002 |
$0.002 |
fallen by
0%
|
|
BP8 - Price-sensitive ASX Announcement
Full Release
Key Points
- BPH Global Ltd has finalized the 'Project 6-7' R&D program for 2026-2027.
- The focus is on extracting gold and silver from seaweed biomass.
- The decision follows assays showing significant metal accumulation in seaweed.
- The program includes two streams: seaweed harvesting and extraction research.
- Collaborations include Gaia Mariculture and academic institutions.
- Initial samples will be harvested from coastal Malaysia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Breville Group Limited (BRG) ORDINARY FULLY PAID |
Consumer Discretionary |
$4,365 |
Notice of FY26 First Half Result and Conference Call
|
8 Jan 2026 9:24AM |
$29.480 |
$30.140 |
risen by
2.24%
|
|
| Parabellum Resources Limited (PBL) ORDINARY FULLY PAID |
Materials |
$5 |
Further Near Surface Ni-Co Mineralisation Intersected
|
8 Jan 2026 9:24AM |
$0.075 |
$0.081 |
risen by
8%
|
|
PBL - Price-sensitive ASX Announcement
Full Release
Key Points
- Further near surface nickel-cobalt mineralization intersected at Miandetta.
- Phase 3 drilling confirms near surface Ni-Co continuity and expands deposit footprint.
- High-grade results developed in saprolite, favorable for acid leach processing.
- Mineralization extended to the west and south at Miandetta.
- Positive drill results support further exploration at Miandetta and Redlands Project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| St George Mining Limited (SGQ) ORDINARY FULLY PAID |
Materials |
$399 |
High-Grade Niobium Discovered Outside Araxa MRE
|
8 Jan 2026 9:23AM |
$0.110 |
$0.105 |
fallen by
4.55%
|
|
SGQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Discovery of high-grade niobium outside existing MRE
- Significant intercept of 81.5m at 1.27% Nb2O5 from surface
- Project located in Brazil's Barreiro Carbonatite
- Potential for expanding the niobium mineral system
- Favorable logistics for open-pit mining
- Lack of domestic niobium supply in US and China
- Ongoing drilling to further define and expand the resource
- Support from Brazilian government for expedited project approvals
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Albright Metals Ltd (ABR) ORDINARY FULLY PAID |
Materials |
$6 |
Antimony Drilling Program Commenced
|
8 Jan 2026 9:22AM |
$0.004 |
$0.004 |
fallen by
0%
|
|